| Amber M Shane, DPM | |
|
250 N Alafaya Trl, Ste 115, Orlando, FL 32828-4315 | |
| (407) 447-1020 | |
| (407) 447-1239 |
| Full Name | Amber M Shane |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 22 Years |
| Location | 250 N Alafaya Trl, Orlando, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013967249 | NPI | - | NPPES |
| P00431274 | Other | FL | RAIL ROAD MEDICARE |
| 340576100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO 3200 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Family Home Health Services | Orlando, FL | Home health agency |
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upperline Healthcare Pc | 4385900653 | 117 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1b/2a clinical study of ISIS-STAT3Rx in patients with advanced metastatic hepatocellular carcinoma (HCC).
Mitt Romney's campaign is rebutting the Democratic National Committee's claims about his record on health reform and abortion rights.
A team of researchers from the University of Saskatchewan has developed two caffeine-based chemical compounds that show promise in preventing the ravages of Parkinson's disease.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
› Verified 7 days ago
| Provider Name | Orlando Foot And Ankle Clinic, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235559188 PECOS PAC ID: 6709778632 Enrollment ID: O20040326000171 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1b/2a clinical study of ISIS-STAT3Rx in patients with advanced metastatic hepatocellular carcinoma (HCC).
Mitt Romney's campaign is rebutting the Democratic National Committee's claims about his record on health reform and abortion rights.
A team of researchers from the University of Saskatchewan has developed two caffeine-based chemical compounds that show promise in preventing the ravages of Parkinson's disease.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
› Verified 7 days ago
| Provider Name | Upperline Healthcare Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538686498 PECOS PAC ID: 4385900653 Enrollment ID: O20201109001904 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1b/2a clinical study of ISIS-STAT3Rx in patients with advanced metastatic hepatocellular carcinoma (HCC).
Mitt Romney's campaign is rebutting the Democratic National Committee's claims about his record on health reform and abortion rights.
A team of researchers from the University of Saskatchewan has developed two caffeine-based chemical compounds that show promise in preventing the ravages of Parkinson's disease.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber M Shane, DPM 3165 Mccrory Pl, Ste 174, Orlando, FL 32803-3727 Ph: (407) 423-1234 | Amber M Shane, DPM 250 N Alafaya Trl, Ste 115, Orlando, FL 32828-4315 Ph: (407) 447-1020 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1b/2a clinical study of ISIS-STAT3Rx in patients with advanced metastatic hepatocellular carcinoma (HCC).
Mitt Romney's campaign is rebutting the Democratic National Committee's claims about his record on health reform and abortion rights.
A team of researchers from the University of Saskatchewan has developed two caffeine-based chemical compounds that show promise in preventing the ravages of Parkinson's disease.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
› Verified 7 days ago
Jawad A. Malik, D.p.m., P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 710 Governors Ave, Orlando, FL 32808 Phone: 407-913-3965 | |
Total Foot And Ankle Center Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10417 Moss Park Road, Orlando, FL 32832 Phone: 407-737-2751 Fax: 407-641-8515 | |
Yanine Maria Velasquez, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13800 Veterans Way, Orlando, FL 32827 Phone: 407-631-1000 | |
Visiting Podiatrist Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 7647 Tern Dr, Orlando, FL 32822 Phone: 407-658-9553 | |
Dr.laurence Richman Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 810 E Colonial Dr, Orlando, FL 32803 Phone: 407-841-8050 Fax: 407-841-1631 | |
Dr. Timothy John Miller, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3701 Avalon Park West Blvd Ste 225, Orlando, FL 32828 Phone: 407-863-3655 Fax: 321-248-3763 |